Overall rank by patents
#3,593
Across all tracked assignees
USPTO PatentsView assignee record - 102 granted patents across 50 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
Dupont holds 102 US patents across 50 technology areas, rank #3,593 of 50,000 tracked assignees.
Dupont Nutrition Biosciences APS has been granted 102 US utility patents between 2015 and 2024, placing Dupont Nutrition Biosciences APS at rank #3,593 across all assignees tracked by PlainPatent. This portfolio spans 50 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.3 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Dupont Nutrition Biosciences APS is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Dupont sits between Bostik Sa (102 patents, rank #3,589) and Inficon Ag (102 patents, rank #3,597) - the closest US assignees by grant volume. The composite Innovation Score of 56.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 33 grants, compared with 69 in the 2015–2019 window, a -52% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Dupont Nutrition Biosciences APS's 16.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 50 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Dupont Nutrition Biosciences APS against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
BOSTIK SA
102 patents
CENTRAL SOUTH UNIVERSITY
102 patents
Colder Products Company
102 patents
Corcept Therapeutics Incorporated
102 patents
G.D SOCIETA' PER AZIONI
102 patents
Genesis Photonics Inc.
102 patents
H.C. STARCK INC.
102 patents
INFICON AG
102 patents
DUPONT NUTRITION BIOSCIENCES APS
102 patents
What this shows Dupont holds 102 patents at rank #3,593, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,593 in granted patent volume.
Other assignees with the most granted patents in Dupont's primary technology class.
Dupont's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
56 Top 6% higher than 94% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 23 | 22.5% |
| 2016 | 18 | 17.6% |
| 2017 | 8 | 7.8% |
| 2018 | 10 | 9.8% |
| 2019 | 10 | 9.8% |
| 2020 | 11 | 10.8% |
| 2021 | 3 | 2.9% |
| 2022 | 10 | 9.8% |
| 2023 | 6 | 5.9% |
| 2024 | 3 | 2.9% |
Top 15 of 50 technology areas
Overall rank by patents
#3,593
Across all tracked assignees
56.1 out of 100
How to use this portfolio
Dupont's 102 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.